RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction
Mengxin Li, Xuyang Chen, Xuanzhong Wang, Xiaodong Wei, Ding Wang, Xiaorui Liu, Libo Xu, Wuren Batu, Yang Li, Baofeng Guo, Ling Zhang
Topics & Concepts
CisplatinIn vivoGlycolysisApoptosisCancer researchProstate cancerPharmacologyCancer cellProgrammed cell deathChemistryBiologyCancerChemotherapyMedicineBiochemistryInternal medicineMetabolismBiotechnologyFerroptosis and cancer prognosisDrug Transport and Resistance MechanismsCancer, Lipids, and Metabolism